These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 18840503

  • 1. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
    Van Broeck B, Vanhoutte G, Cuijt I, Pereson S, Joris G, Timmermans JP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S.
    Neurosci Lett; 2008 Dec 12; 447(2-3):143-7. PubMed ID: 18840503
    [Abstract] [Full Text] [Related]

  • 2. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S.
    Neurobiol Aging; 2008 Feb 12; 29(2):241-52. PubMed ID: 17112635
    [Abstract] [Full Text] [Related]

  • 3. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG, Lin YG, Lang DM, Trusko SP, Hirsch JD, Savage MJ, Scott RW, Howland DS.
    Neurobiol Aging; 2009 Jul 12; 30(7):1078-90. PubMed ID: 18053619
    [Abstract] [Full Text] [Related]

  • 4. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
    Lee KW, Lee SH, Kim H, Song JS, Yang SD, Paik SG, Han PL.
    J Neurosci Res; 2004 May 15; 76(4):572-80. PubMed ID: 15114629
    [Abstract] [Full Text] [Related]

  • 5. RAGE does not affect amyloid pathology in transgenic ArcAbeta mice.
    Vodopivec I, Galichet A, Knobloch M, Bierhaus A, Heizmann CW, Nitsch RM.
    Neurodegener Dis; 2009 May 15; 6(5-6):270-80. PubMed ID: 20145420
    [Abstract] [Full Text] [Related]

  • 6. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J.
    Neuroscience; 2004 May 15; 125(4):1009-17. PubMed ID: 15120860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 15; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 9. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.
    Abrahamson EE, Ikonomovic MD, Ciallella JR, Hope CE, Paljug WR, Isanski BA, Flood DG, Clark RS, DeKosky ST.
    Exp Neurol; 2006 Feb 15; 197(2):437-50. PubMed ID: 16300758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
    Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, Danner S, Abramowski D, Stürchler-Pierrat C, Bürki K, van Duinen SG, Maat-Schieman ML, Staufenbiel M, Mathews PM, Jucker M.
    Nat Neurosci; 2004 Sep 15; 7(9):954-60. PubMed ID: 15311281
    [Abstract] [Full Text] [Related]

  • 12. Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease.
    Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browman KE.
    Brain Res; 2010 Jan 22; 1311():136-47. PubMed ID: 19944081
    [Abstract] [Full Text] [Related]

  • 13. Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model.
    Rönnbäck A, Zhu S, Dillner K, Aoki M, Lilius L, Näslund J, Winblad B, Graff C.
    Neurobiol Aging; 2011 Feb 22; 32(2):280-92. PubMed ID: 19329229
    [Abstract] [Full Text] [Related]

  • 14. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O, Hammarström P, Nilsson KP, Portelius E, Olofsson T, Ingelsson M, Hyman BT, Blennow K, Lannfelt L, Kalimo H, Nilsson LN.
    Neurobiol Aging; 2009 Sep 22; 30(9):1393-405. PubMed ID: 18192084
    [Abstract] [Full Text] [Related]

  • 15. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ, Kulnane LS, Gao Y, Petriello MC, Pimpis KM, Younkin L, Dolios G, Wang R, Younkin SG, Lamb BT.
    Hum Mol Genet; 2003 Nov 15; 12(22):2949-56. PubMed ID: 14506131
    [Abstract] [Full Text] [Related]

  • 16. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression.
    Krezowski J, Knudson D, Ebeling C, Pitstick R, Giri RK, Schenk D, Westaway D, Younkin L, Younkin SG, Ashe KH, Carlson GA.
    Hum Mol Genet; 2004 Sep 15; 13(18):1989-97. PubMed ID: 15254013
    [Abstract] [Full Text] [Related]

  • 17. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O, Lannfelt L, Nilsson LN.
    FEBS Lett; 2009 Sep 17; 583(18):3021-6. PubMed ID: 19683527
    [Abstract] [Full Text] [Related]

  • 18. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.
    Santiard-Baron D, Langui D, Delehedde M, Delatour B, Schombert B, Touchet N, Tremp G, Paul MF, Blanchard V, Sergeant N, Delacourte A, Duyckaerts C, Pradier L, Mercken L.
    J Neurochem; 2005 Apr 17; 93(2):330-8. PubMed ID: 15816856
    [Abstract] [Full Text] [Related]

  • 19. Prion protein (PrPc) promotes beta-amyloid plaque formation.
    Schwarze-Eicker K, Keyvani K, Görtz N, Westaway D, Sachser N, Paulus W.
    Neurobiol Aging; 2005 Apr 17; 26(8):1177-82. PubMed ID: 15917101
    [Abstract] [Full Text] [Related]

  • 20. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, Haass C, Van Leuven F, Staufenbiel M, Capetillo-Zarate E.
    Neurobiol Aging; 2007 Aug 17; 28(8):1221-30. PubMed ID: 16815595
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.